Estimating regional bone mineral density-based T-scores using clinical information; tools validated for postmenopausal women in Sri Lanka
10.1016/j.afos.2020.08.004
- Author:
Hewa Walpola Amila SEWWANDI SUBASINGHE
1
;
Sarath EKAMWASAM
;
Patrick BALL
;
Hana MORRISSEY
;
Eisha WAIDYARATNE
Author Information
1. Department of Pharmacy, Faculty of Allied Health Sciences, University of Ruhuna, Sri Lanka
- Publication Type:Original Article
- From:Osteoporosis and Sarcopenia
2020;6(3):122-128
- CountryRepublic of Korea
-
Abstract:
Objectives:This study aims to develop and validate a country specific osteoporosis risk assessing tool for Sri Lankan postmenopausal women.
Methods:Community-dwelling postmenopausal women were enrolled to development (n ¼ 602) and validation (n ¼ 339) samples. Clinical risk factors (CRFs) of osteoporosis were assessed. Bone mineral densities (BMD) of femoral neck, total hip and lumbar spine were assessed by dual energy X-ray absorptiometry (DXA) scan. Radial ultrasound (US) bone scan was done. Linear regression analysis was performed in development sample considering regional BMDs as dependent and CRFs as independent variables. Regression equations were developed to estimate regional BMDs using best predictive CRFs.Sensitivity, specificity, positive and negative predictive values (PPV and NPV) were assessed to validate the new tools.
Results:Age, body weight and US T-scores showed positive correlations with BMDs of all 3 sites. Two osteoporosis risk assessing tools (OPRATs) were developed as OPRAT-1 and OPRAT-2. Prevalence of osteoporosis, in the validation sample was 74.3%. Sensitivity were high in both tools (OPRAT-1 and OPRAT-2; 83.2% and 82.5%) while specificity were moderate (44.8% for both). PPV of OPRAT-1 and OPRAT-2 were 79.5% and 81.2%. Both tools showed moderate NPV (OPRAT-1 and OPRAT-2; 51% and 47%).
Conclusions:Both OPRAT-1 and OPRAT-2 have high performance in screening postmenopausal women in Sri Lanka for risk of osteoporosis. OPRAT-2 is more convenient and can be used in any healthcare setting with limited resources to identify women who will be benefitted by DXA. OPRAT-1 can be used if the radial US facility is available.
